Results 241 to 250 of about 22,816,528 (289)
Some of the next articles are maybe not open access.

Use of protein C concentrate in neonatal period.

open access: yesMinerva pediatrica, 2010
Levels of protein C, low at birth, physiologically Increase until six months of age and achieve the adult range after puberty. Protein C deficiency may be congenital or acquired. Severe protein C deficiency is a rare autosomal recessive disorder that usually presents in neonatal period with purpura fulminans. Acquired protein C deficiency may be caused
De Carolis, Maria Pia
openaire   +3 more sources

Homozygous protein C deficiency—management with protein C concentrate

European Journal of Pediatrics, 1995
Two unrelated female infants with homozygous protein C (Pr C) deficiency are reported. Both are of U.K. Pakistani origin and in each case the parents are consanguinous. A previous sibling had died in each family. Both sets of parents were shown to be carriers. The concentration of Pr C in both infants was low at birth.
V, Baliga   +5 more
openaire   +2 more sources

SUBCUTANEOUS ADMINISTRATION OF PROTEIN C CONCENTRATE

Pediatric Hematology and Oncology, 2004
Children born with severe homozygous protein C deficiency do not survive beyond the neonatal period unless they receive protein C replacement. Protein C concentrate (Baxter Biosciences, Vienna) is usually given intravenously via a central venous catheter The authors describe 2 children in whom protein C concentrate was successfully administered by ...
M, Mathias   +3 more
openaire   +2 more sources

DEVELOPMENT OF A PROTEIN C CONCENTRATE

Thrombosis and Haemostasis, 1987
A Protein C (PC) concentrate may be useful in treating patients with congenital or acquired Protein C deficiencies. A method for preparation of a human Protein C concentrate has been developed using a by-product of American Red Cross Factor IX production as the starting material (Menache et. al. Blood, 64, 1220).
Prabir Bhattacharya   +2 more
openaire   +1 more source

Treatment of homozygous protein C deficiency with subcutaneous protein C concentrate

British Journal of Haematology, 1996
Subcutaneous protein C concentrate (Immuno, Vienna) was used to treat a child with homozygous protein C deficiency who was formerly treated with intravenous protein C concentrate. After 3000 units subcutaneous protein C concentrate (250 iu/kg), protective protein C levels were maintained for 48h after infusion, with peak levels at 12h.
A M, Minford   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy